Breaking News

You are here » Indian-Commodity  :  IPO  :  Shakun Polymers files DRHP with SEBI for IPO

05-May2018

Shakun Polymers files DRHP with SEBI for IPO

Shakun Polymers has filed a Draft Red Herring Prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise funds through an Initial Public Offering (IPO). The offer comprises of fresh issue of equity shares aggregating up to Rs 75 crore and an offer for sale of up to 18 lakh equity shares by selling shareholders.

The company proposes to utilize the net proceeds from the issue towards setting up of new unit for manufacturing Halogen Free Flame Retardant (HFFR) compounds and general corporate purpose. The equity shares are proposed to be listed on the BSE and the NSE.

Vivro Financial Services is the book running lead manager to the offer, while Link Intime India is the registrar to the issue.

Shakun Polymers, a leading player in the field of compounding for the wire & cable market, is also one of the first movers in India for manufacturing of HFFR compounds and one of the leading exporters for HFFR compounds from India.



Related News

View all news

Spandana Sphoorty gets SEBI's nod for IPO

Spandana Sphoorty Financial has received markets regulator Securities and Exchange Board of India's (SEBI) approval to raise funds through an initial public offering (IPO). The IPO consists of fresh issue......

Bharat Hotels gets SEBI's approval for IPO

Bharat Hotels has received markets regulator Securities and Exchange Board of India's (SEBI) approval to raise funds through an initial public offering (IPO). The IPO comprises sale of fresh equity shares......

Chartered Speed files DRHP with SEBI for public issue

Fleet bus operators Chartered Speed has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise an estimated Rs 273 crore through an Initial......

Top News

View all news

Zydus Cadila gets USFDA's approval for Nystatin and Triamcinolone Acetonide Ointment

Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Nystatin and Triamcinolone Acetonide Ointment USP, (US RLD -Mycolog-II Ointment), 100,000......

Tata Steel flags-off Art Residency Programme at CFE Jamshedpur

Tata Steel has flagged off the first-ever Art Residency Programme in Jamshedpur under the aegis of the Centre for Excellence (CFE) Jamshedpur.The 12-day Art Residency aims to offer a platform for artistic......

Sobha reports 22% rise in Q2 consolidated net profit

Sobha has reported results for second quarter ended September 30, 2018.The company has reported a rise of 28.76% in its net profit at Rs 57.30 crore for the quarter under review as compared to Rs 44.50......